baber/WOPTO huggingface dataset:
Patent CA-2559464-A1 (CA)
Inventor: WHITE GALE
IPC: G16H20/17
Filed: 2005-03-14
Abstract: A wireless communication system from an IV medication infusion pump (10) to a hospital information management system (HIMS) is disclosed). The system includes an IV pump having pump operation circuitry (41, 43) for monitoring pre-selected characteristics (15) of pump operation indicative of IV  administration of medication to a patient (20). A transmitter or transceiver (45) is connected to the pump operation circuitry (41) for receiving a wireless pump signal (67) representing instructional data to the IV pump and for transmitting a wireless pump signal representing the pre-selected pump operation characteristics (15). The wireless pump transmitter or transceiver (45) communicates with the HIMS (60). The HIMS includes a receiver or transceiver (61) capable of transmitting and receiving the pump signal (49) representing the pump operation characteristics (15) and also includes a computer processor (57) capable of storing and displaying the pump operation characteristics that are represented by the received wireless pump signal. In one embodiment, a data collection terminal (180) is incorporated into the system. The data collection terminal (180) includes a transceiver (182) capable of transmitting and receiving the pump signal (49) representing the pump operation characteristics and the HIMS signal (67) representing instruction data to the IV pump (10).
Patent CA-2561593-A1 (CA)
Title: Antiobesity drug
Inventor: OIKE YUICHI
IPC: A23L1/305
Filed: 2005-03-30
Abstract: An antiobesity drug, a remedy for diabetes and/or a remedy for hyperlipemia containing angiopoietin-related growth factor (AGF) or a polynucleotide encoding the same as the active ingredient; a functional food or a health food containing AGF as the active ingredient and having a function of ameliorating obesity, diabetes and/or hyperlipemia imparted thereto; a method of preventing or treating obesity, diabetes and/or hyperlipemia which comprises administering AGF or a polynucleotide encoding the same; and utilization of AGF or a polynucleotide encoding the same for producing an antiobesity drug, a remedy for diabetes and/or a remedy for hyperlipemia.
Patent CA-2565891-A1 (CA)
Inventor: DOLL PAUL EDWARD
IPC: B31B50/00
Filed: 2006-10-27
Abstract: A carton formed from a unitary blank for storing food within and methods of manufacture of the carton thereform, are disclosed herein. The carton comprises a generally rectangular bottom having a pair of major bottom flaps and a pair of minor bottom flaps that are folded to form a substantially closed bottom, and a pair of major side panels, a pair of minor side panels, and a secondary side panel that are folded perpendicular to the bottom. An opening is defined by the upper ends of the major side panels and the minor side panels opposite the bottom and is generally non-rectangular.
Patent CA-2566586-A1 (CA)
Title: Packaging for digital obliquely stored discs
Inventor: GIRAUD CHARLES-HENRI
IPC: G11B33/04
Filed: 2005-06-17
Abstract: The inventive packaging for a plurality of digital discs ( 10 ) comprises means for maintaining the discs ( 10 ) in a storage positions thereof, wherein said discs ( 10 ) extend on an oblique plane with respect to the packaging and is characterised in that it comprises a tray ( 20 ) which has a large surface provided with a disc reception area ( 30 ) arranged thereon, defined by a bottom ( 31 ) and comprising the edges ( 32, 34 ) and which also comprises means ( 40 ) for holding discs ( 10 ) inside the reception area ( 30 ) in the oblique storage position thereof, wherein the discs ( 10 ) extend on the oblique plane with respect to the bottom ( 31 ) in a partially spaced and overlapping manner.
Patent CA-2566655-A1 (CA)
Title: Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Inventor: HALL WARREN
IPC: A61K9/20
Filed: 2005-05-25
Abstract: The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof.
Patent CA-2566703-A1 (CA)
Title: Methods of inhibiting proinflammatory cytokine expression using ghrelin
Inventor: TAUB DENNIS D
IPC: A61K38/17
Filed: 2005-05-11
Abstract: The present invention provides a method of inhibiting proinflammatory cytokine expression using ghrelin.
Patent CA-2568396-A1 (CA)
Inventor: TYSOWSKI PIOTR K
IPC: G06F3/023
Filed: 2006-11-17
Abstract: The invention provides a system and a method of processing keystrokes being entered in an electronic device is provided. The method comprises: monitoring for activation of two or more keys on the device; determining whether a keystroke conflict occurs from the activation of the keys; and if a conflict has occurred, then executing further steps. The further steps include: identifying a selected key from the activated keys; generating a character associated with the selected key; and ignoring activation of any keys other than the selected key. The system comprises an electronic device with a display, a keypad and modules which perform the steps of the method as noted.
Patent CA-2570486-A1 (CA)
Title: Integrated nanotube and field effect switching device
Inventor: BERTIN CLAUDE L
IPC: H03K19/20
Filed: 2005-05-26
Abstract: Hybrid switching devices (10) integrate nanotube switching elements (20) with field effect devices (30), such as NFETs and PFETs. A switching device forms and unforms a conductive channel from the signal input to the output subject to the relative state of the control input. In embodiments of the invention, the conductive channel includes a nanotube channel element (20) and a field modulatable semiconductor channel element (30). The switching device may include a nanotube switching element and a field effect device electrically disposed in series. According to one aspect of the invention, an integrated switching device is a four-terminal device with a signal input terminal (25), a control input terminal (40~), a second input terminal (40), and an output terminal (45). The devices may be non-volatile. The devices can form the basis for a hybrid NT-FET logic family and can be used to implement any Boolean logic circuit.
Patent CA-2575478-A1 (CA)
Inventor: FURGAL BERNARD
IPC: G01C25/00
Filed: 2005-09-19
Abstract: A device (1) comprises an inertial reference station (7) for measuring the aircraft heading, an inertial reference unit (9) which is mountable on the wheel of a nose landing gear by means of a fixing system and is used for measuring the heading of said landing gear in a non-steering position and a data processing unit (11) comprising means (12, 13) for carrying out a comparison between the measured heading of the nose landing gear and the measured aircraft heading in such a way that the orientation of said nose landing gear is calculated with respect to the aircraft body.
Patent CA-2577196-A1 (CA)
Inventor: EREZ NETA
IPC: A61K38/10
Filed: 2005-08-23
Abstract: The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing peptides recognized by monoclonal anti-DNA antibodies, the peptides having anti-apoptotic and anti-inflammatory activity. The invention further provides antibody molecules and uses thereof for the isolation of such peptides.
Patent CA-2577315-A1 (CA)
Title: Detonation safety in microchannels
Inventor: JAROSH KAI
IPC: B01J19/24
Filed: 2005-08-02
Abstract: The proper sizing of microchannel dimensions and the management of internal features offer the possibility of inherently safe operation within the flammable limits of a combustible fluid stream while preserving the largest-possible flow dimensions for industrial-scale process capacity. Specifically, the microchanne! dimensions need not be restricted to gap distances below the quenching distance to be operated safely. Microchannel performance can be engineered to provide adequate heat transfer for flame propagation. However.  it is essential to maintain flame characteristics in such a manner that it cannot transition to a detonation flame front. A detonation takes place when the combustion wave propagates at supersonic speeds at the existing local temperature and pressure conditions in the system. It results in a much larger energy release over a much smaller period of time as compared to a laminar flame or deflagration. the later of which is a combustion wave propagating at subsonic speed. Detonations can be potentially highly destructive and very hazardous and therefore should be avoided for most industrial applications.
Patent CA-2577587-A1 (CA)
Title: Method and apparatus for analyzing amniotic fluid
Inventor: BURNS DAVID H
IPC: A61B8/00
Filed: 2004-08-21
Abstract: Methods and spectra for monitoring fetal growth and predicting birth weight of an infant prior to birth are provided wherein one or more selected biological markers are measured in a sample of amniotic fluid obtained from a pregnant woman. Levels of the selected biochemical markers and/or spectra correlate with one or more medical conditions, such as fetal growth and birth weight of the infant, and gestational diabetes. A measurement probe for in situ measurement can be used safely and repeatedly. Monitoring and/or treatment of maternal and fetal health is also provided.
Patent CA-2581932-A1 (CA)
Title: A method of female contraception and a kit for use therein
Inventor: COELINGH BENNINK HERMAN JAN TI
IPC: A61P15/18
Filed: 2004-09-27
Abstract: The invention is concerned with a method of contraception in a female mammal of childbearing capability, said method consisting of two alternating phases -a preservation phase and a shedding phase - and comprising at least two sequences of (~a). a preservation phase of 3 -12 months comprising continuous oral administration to the female of dosage units containing: (i) an estrogen selected from the group consisting of 17.beta.-estradiol, esters of 17.beta. -estradiol and combinations thereof, in an amount equivalent to a daily oral dosage of 2.2-5 mg 17.beta. -estradiol, and (ii) a progestogen in an amount equivalent to a daily oral dosage of 30-750 ~g levonorgestrel; and (b). a shedding phase of 4-12 days during which no progestogen is administered. The invention also relates to a contraceptive kit comprising one or more packaging units comprising separately packaged, individually removable oral dosage units for use in the aforementioned contraceptive method.
Patent CA-2582367-A1 (CA)
Title: Resource allocation in communication networks
Inventor: WAN LEI
IPC: H04B7/26
Filed: 2004-10-29
Abstract: A method of adapting resource allocation parameters to reach one or more quality targets with improved accuracy is proposed. New information measurements based on the so-called mutual information, preferably at block-level, are introduced. The MI-based information measurements of a previous transmission, the channel prediction of a subsequent transmission and one or more quality requirements, are used to determine the amount and type of resources, e.g. time, frequency and power resources, that are to be used for the subsequent transmission. The resource allocation can for example comprise power allocation and/or link adaptation and the invention enables an advantageous implementation with cooperative link-adaptation and power allocation. The proposed method is useful in connection with ARQ/HARQ  retransmissions.
Patent CA-2584826-A1 (CA)
Inventor: REID JOHN NICHOLAS
IPC: B67D3/04
Filed: 2005-10-14
Abstract: A sphincter valve has a membrane (10) formed with at least one slit (12) defined by petals, which membrane (10) adopts a convex dished configuration when the valve is closed and inverts into a concave configuration when the valve is opened. In the invention, an abutment member (16) is movable relative to the membrane (10) for opening the valve by making direct contact with the petals to open the slit between the petals.
Patent CA-2587192-A1 (CA)
Title: Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
Inventor: DESIMONE ROBERT W
IPC: A61P35/00
Filed: 2005-11-10
Abstract: Chemical entities chosen from compounds of Formula (I), and pharmaceutically acceptable salts, solvates, crystal forms, chelates, non-covalent complexes, prodrugs, and mixtures thereof, are described herein. Pharmaceutical compositions comprising at least one chemical entity of Formula (I), together with at least one pharmaceutically acceptable vehicle chosen from carriers adjuvants, and excipients, are described. Methods of treating patients suffering from certain diseases responsive to inhibition of Btk activity and/or B-cell proliferation are described. Methods for determining the presence of Btk in a sample are described.
Patent CA-2587328-A1 (CA)
Title: Novel derivatives of porphyrin, particularly chlorins and/orbacteriochlorins, and uses thereof in photodynamic therapy
Inventor: MONTEIRO CARLOS
IPC: C07D487/22
Filed: 2005-11-10
Abstract: The invention relates to derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, which can be used in photodynamic therapy. According to the formulas of the invention, X1, X2, X3, X4, X5, X6, X7, X8, which may be identical or different, each represent halogen atoms or hydrogen atoms. R1, R2, R3, R4, which may be identical or different, are each selected from the following groups: -OH, amino acids, -OR and -NHR and/or a chlorine atom, wherein R is an alkyl group having between 1 and 12 carbon atoms. The invention also relates to an anticancer and/or antiviral and/or antimicrobial medicament for human or animal use, which contains one or more compounds as the main active ingredient.
Patent CA-2590004-A1 (CA)
Title: Contraceptive pharmaceutical preparation
Inventor: GRAESER THOMAS
IPC: A61P15/18
Filed: 2006-02-15
Abstract: The invention relates to a pharmaceutical composition containing dienogest at an amount that corresponds to a daily dose unit of 1.5 mg or 2.0 mg when the composition is administered and ethinyl estradiol at an amount which corresponds to a daily dose unit of 0.015 mg or 0.020 mg when the composition is administered, together with one or several pharmaceutically acceptable carriers for at least 21 daily dose units. The invention further relates to an oral contraceptive pharmaceutical preparation containing 1.5 mg of 17.alpha.-cyanomethyl-17-~-hydroxyestra-4,9-dien-3on (dienogest) and 0.015 or 0.020 mg of 17a-ethinyl estradiol (ethinyl estradiol) or 2.0 mg dienogest and 0.015 mg ethinyl estradiol along with one or several pharmaceutically acceptable carriers for at least 21 daily dose units of a 28-day menstruation cycle.
Patent CA-2590289-A1 (CA)
Title: Filled polymer composites
Inventor: SHEFELBINE TERRI A
IPC: C08L53/00
Filed: 2005-12-09
Abstract: Provided are compositions comprising a polymeric matrix; a plurality of fillers; and a block copolymer wherein at least one segment of the block copolymer interacts with the fillers. Also provided are composition comprising a plurality of fillers having surfaces and a block copolymer wherein at least one segment of the block copolymer is capable of interacting with the fillers upon application in a polymeric matrix. Compositions comprising a flame retardant compound and a block copolymer wherein at least one segment of the block copolymer is capable of interacting with the flame retardant compound upon application in a polymeric matrix are also provided.
Patent CA-2592087-A1 (CA)
Title: Reinforced polyurethane urea elastomers and use thereof
Inventor: HAAS PETER
IPC: C08G18/48
Filed: 2005-12-13
Abstract: The invention relates to reinforced polyurethane-urea elastomers with a specific urea content and a specific urethane content, to sheet polyurethane moldings with high surface energy and good lacquer adhesion produced therefrom, and to their use.
Patent CA-2592349-A1 (CA)
Title: Filter removal devices
Inventor: SUNDET DOUGLAS C
IPC: B01D46/42
Filed: 2005-12-01
Abstract: A device for facilitating removal of a filter from an air circulation system includes a flexible element having a first, low profile position adjacent a surface of the filter and a second, extended position spaced from the surface of the filter. When in the extended position the flexible element provides a graspable or grippable medium for removing the filter from the air circulation system. The device also includes attaching means for securing the flexible element to the filter.
Patent CA-2592467-A1 (CA)
Title: Glycine transport inhibitors
Inventor: LAI JUSTINE YEUN QUAI
IPC: C07C233/78
Filed: 2005-12-21
Abstract: The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
Patent CA-2592659-A1 (CA)
Title: Fcc feed injection for atomizing feed
Inventor: SMALLEY CHRISTOPHER G
IPC: C10G11/18
Filed: 2005-12-06
Abstract: This invention relates to an apparatus and process for injecting a petroleum feed. More particularly, a liquid petroleum feed is atomized with a nozzle assembly apparatus in which the apparatus has injection nozzles that produce a spray pattern of finely dispersed feed. The injection nozzles are each designed such that the overall effect of the different spray patterns from the individual nozzles provides a more uniform feed coverage across the catalyst stream, provided that at least one spray pattern is not substantially flat.
Patent CA-2592934-A1 (CA)
Inventor: NUENSWANDER JACOB
IPC: A47C23/04
Filed: 2006-01-09
Abstract: A nestably stackable bedding foundation assembly (10) replaces the traditional border wire and disposed coil spring foundation assembly in a so-called box spring. The foundation assembly (10) may be nestably stacked with numerous other such assemblies for transportation, thereby avoiding the need to compress and tie the assembly for shipping. Each foundation assembly (10) includes a number of corrugated support wires (28) having alternating peaks (32) and valleys (34). The valleys (34) of selected support wires (28) are twisted relative to their associated peaks (32) to provide a more stable mounting to a base (12) and offer a variety of firmness to specific zones of the assembly (10).
Patent CA-2593830-A1 (CA)
Inventor: WAISANEN STEVEN K
IPC: B23P19/04
Filed: 2005-01-12
Abstract: A pin removal assembly for use with an upper block of a Grane includes a sheave support and a pin support. The upper block includes a frame, a plurality of sheaves, and a removable sheave pin that defines an axis of rotation for the sheaves and supports the sheaves within the frame. The pin removal assembly includes a sheave support mountable to the frame of the upper block and a pin support mountable to the frame of the upper block. The pin support is configured to support the sheave pin when the sheave pin is removed from the upper block.
Patent CA-2596807-A1 (CA)
Title: Method for the photochemical attachment of biomolecules to a substrate
Inventor: CHATELAIN FRANCOIS
IPC: C12Q1/68
Filed: 2005-02-10
Abstract: Methods and devices for attaching biomolecules to a solid substrate surface for example to the inner surface of a capillary. In particular, the invention relates to compounds and methods for creating patterned arrays of biomolecules inside fused silica capillaries so that a plurality of bioassays can be conducted simultaneously.
Patent CA-2597483-A1 (CA)
Inventor: FROMAN GARY S
IPC: H05B1/02
Filed: 2005-05-16
Abstract: Système de gestion de glace pour un aéronef ayant au moins un rotor (11), chaque rotor ayant une pluralité de lames. Le système a une alimentation électrique par courant alternatif (CA) pour fournir une alimentation CA (13), l~alimentation électrique CA étant apte à être transportée par l~avion à l~écart du rotor (11). Un convertisseur convertit l~alimentation CA en une alimentation par courant continu (CC). Au moins un dispositif de protection contre la glace est transporté par le rotor et fonctionne à l~aide de l~alimentation CC.
Patent CA-2599011-A1 (CA)
Inventor: CHAPELLO WILLIAM J
IPC: A23L27/30
Filed: 2006-02-27
Abstract: A brown sugar substitute containing a high intensity sweetener, molasses, a food grade crystalline sugar or sugar alcohol, and at least one anti-caking agent is provided. Compositions containing the brown sugar substitutes and packaged forms of the brown sugar substitutes are also provided. Further provided are methods of making the brown sugar substitutes.
Patent CA-2599132-A1 (CA)
Inventor: RUBIN ELDAD
IPC: B60C5/22
Filed: 2006-02-28
Abstract: A run-flat tire of improved load bearing capacity after being punctured is disclosed. The tire has two circumferential sidewalls, at least one circumferential intermediate wall interposed between the sidewalls, and a transverse base extending from one sidewall to the other and defining a compartment between a sidewall and an adjacent intermediate wall or between two adjacent intermediate walls. Each compartment is adapted to assume an expanded symmetrical configuration when an adjacent sidewall or intermediate wall is punctured. A carcass portion is provided within each sidewall, each intermediate wall and base. A shock absorber is provided in the vicinity of a junction connecting each intermediate wall to the base. A padding element is affixed to the inner liner portion applied to the bead wrap of each intermediate wall.
Patent CA-2599498-A1 (CA)
Title: Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
Inventor: ATES CELAL
IPC: C07D207/28
Filed: 2006-02-23
Abstract: The present invention relates to (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(R)-pyrrolidone-5-carboxylicacid salt; or (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxycetamide-(R)-pyrrolidone-5-carboxylic salt. The present invention relates also to a process for preparing (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide (I) and (R)-2-[4-(4-chlorobenzhydryl) piperazin-1-yl]-ethoxyacetamide (II) by chemical resolution of a mixture. These compounds are respectively intermediates for the synthesis of dextrocetirizine and levocetirizine.
Patent CA-2600231-A1 (CA)
Title: Exhaust structure of industrial vehicle
Inventor: NAKANO RYUJI
IPC: B66F9/075
Filed: 2007-09-06
Abstract: An exhaust structure for a forklift having an engine mounted in a rear section is disclosed. The exhaust structure includes a conducting pipe, a sub-muffler, and a sub-exhaust pipe. The conducting pipe conducts exhaust gas discharged from the engine to a front section of the forklift. The sub--muffler is arranged in a front section of the forklift and connected to the conducting pipe. The sub-exhaust pipe conducts exhaust gas that has passed through the sub-muffler to the rear section of the forklift. The conducting pipe, the sub-muffler, and the sub-exhaust pipe are attached to a lower portion of the forklift.